Description
STAYBRED™ VL5 is a suspension of inactivated Campylobacter fetus, Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. STAYBRED VL5 contains Amphigen™, a patented oil-in-water lecithin emulsion that enhances and prolongs the immune response while minimizing injection-site reactions and carcass trimout.

Approved Uses

Vaccination of healthy cows and heifers as an aid in preventing campylobacteriosis (vibriosis) caused by Campylobacter fetus, and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.

Key Features

- Helps prevent two of the most common bovine reproductive diseases —campylobacteriosis (vibriosis) and leptospirosis.

- Preventive vaccination is the most cost-effective way of controlling two reproductive diseases that can be difficult to detect, particularly in adult cattle. Campylobacteriosis and leptospirosis can silently reduce herd productivity due to open cows, smaller calf crops, delayed conception, and a strung-out calving season.

- Efficacy of each of the Campylobacter and Leptospira components in STAYBRED VL5 was confirmed by challenge-of-immunity. Serologic tests determined that there was no immunologic interference among the components in STAYBRED VL5.

Packaging

10- and 50-dose vials